| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 59651-118-05 | 59651-118 | HUMAN PRESCRIPTION DRUG | Dofetilide | Dofetilide | CAPSULE | ORAL | 20190122 | N/A | ANDA | ANDA210740 | Aurobindo Pharma Limited | DOFETILIDE | .125 mg/1 | 500 CAPSULE in 1 BOTTLE (59651-118-05) |
| 59651-118-60 | 59651-118 | HUMAN PRESCRIPTION DRUG | Dofetilide | Dofetilide | CAPSULE | ORAL | 20190122 | N/A | ANDA | ANDA210740 | Aurobindo Pharma Limited | DOFETILIDE | .125 mg/1 | 60 CAPSULE in 1 BOTTLE (59651-118-60) |
| 59651-120-05 | 59651-120 | HUMAN PRESCRIPTION DRUG | Dofetilide | Dofetilide | CAPSULE | ORAL | 20190122 | N/A | ANDA | ANDA210740 | Aurobindo Pharma Limited | DOFETILIDE | .5 mg/1 | 500 CAPSULE in 1 BOTTLE (59651-120-05) |
| 59651-120-60 | 59651-120 | HUMAN PRESCRIPTION DRUG | Dofetilide | Dofetilide | CAPSULE | ORAL | 20190122 | N/A | ANDA | ANDA210740 | Aurobindo Pharma Limited | DOFETILIDE | .5 mg/1 | 60 CAPSULE in 1 BOTTLE (59651-120-60) |
| 59651-119-05 | 59651-119 | HUMAN PRESCRIPTION DRUG | Dofetilide | Dofetilide | CAPSULE | ORAL | 20190122 | N/A | ANDA | ANDA210740 | Aurobindo Pharma Limited | DOFETILIDE | .25 mg/1 | 500 CAPSULE in 1 BOTTLE (59651-119-05) |
| 59651-119-60 | 59651-119 | HUMAN PRESCRIPTION DRUG | Dofetilide | Dofetilide | CAPSULE | ORAL | 20190122 | N/A | ANDA | ANDA210740 | Aurobindo Pharma Limited | DOFETILIDE | .25 mg/1 | 60 CAPSULE in 1 BOTTLE (59651-119-60) |